These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23973720)

  • 21. Brain amino acid abnormalities in pyruvate carboxylase deficiency.
    Perry TL; Haworth JC; Robinson BH
    J Inherit Metab Dis; 1985; 8(2):63-6. PubMed ID: 2878111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI, clinical, and biochemical features of partial pyruvate carboxylase deficiency.
    Higgins JJ; Glasgow AM; Lusk M; Kerr DS
    J Child Neurol; 1994 Oct; 9(4):436-9. PubMed ID: 7822739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GABAergic projection from the ventral tegmental area and substantia nigra to the periaqueductal gray region and the dorsal raphe nucleus.
    Kirouac GJ; Li S; Mabrouk G
    J Comp Neurol; 2004 Feb; 469(2):170-84. PubMed ID: 14694532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats.
    Ampe B; Massie A; D'Haens J; Ebinger G; Michotte Y; Sarre S
    J Neurochem; 2007 Nov; 103(3):1063-74. PubMed ID: 17727638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal diagnosis of pyruvate carboxylase deficiency by direct measurement of catalytic activity on chorionic villi samples.
    Van Coster RN; Janssens S; Misson JP; Verloes A; Leroy JG
    Prenat Diagn; 1998 Oct; 18(10):1041-4. PubMed ID: 9826895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wang T
    Brain Res; 2010 Apr; 1324():54-63. PubMed ID: 20149784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colocalization of excitatory and inhibitory neurotransmitter markers in striatal projection neurons in the rat.
    White LE; Hodges HD; Carnes KM; Price JL; Dubinsky JM
    J Comp Neurol; 1994 Jan; 339(3):328-40. PubMed ID: 7907614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insights on pathogenic effects of novel mutations causing pyruvate carboxylase deficiency.
    Monnot S; Serre V; Chadefaux-Vekemans B; Aupetit J; Romano S; De Lonlay P; Rival JM; Munnich A; Steffann J; Bonnefont JP
    Hum Mutat; 2009 May; 30(5):734-40. PubMed ID: 19306334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
    Willemsen MA; Verbeek MM; Kamsteeg EJ; de Rijk-van Andel JF; Aeby A; Blau N; Burlina A; Donati MA; Geurtz B; Grattan-Smith PJ; Haeussler M; Hoffmann GF; Jung H; de Klerk JB; van der Knaap MS; Kok F; Leuzzi V; de Lonlay P; Megarbane A; Monaghan H; Renier WO; Rondot P; Ryan MM; Seeger J; Smeitink JA; Steenbergen-Spanjers GC; Wassmer E; Weschke B; Wijburg FA; Wilcken B; Zafeiriou DI; Wevers RA
    Brain; 2010 Jun; 133(Pt 6):1810-22. PubMed ID: 20430833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].
    Blanco-Lezcano L; Rocha-Arrieta LL; Alvarez-González L; Martínez-Martí L; Pavón-Fuentes N; González-Fraguela ME; Bauzá-Calderín Y; Coro-Grave de Peralta Y
    Rev Neurol; 2005 Jan 1-15; 40(1):23-9. PubMed ID: 15696422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
    Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry.
    Ribak CE; Vaughn JE; Roberts E
    J Comp Neurol; 1979 Sep; 187(2):261-83. PubMed ID: 226567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats.
    Mukhida K; Hong M; Miles GB; Phillips T; Baghbaderani BA; McLeod M; Kobayashi N; Sen A; Behie LA; Brownstone RM; Mendez I
    Brain; 2008 Aug; 131(Pt 8):2106-26. PubMed ID: 18669492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons.
    Dallvechia-Adams S; Kuhar MJ; Smith Y
    J Comp Neurol; 2002 Jul; 448(4):360-72. PubMed ID: 12115699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyruvate carboxylase deficiency: a benign variant with normal development.
    Van Coster RN; Fernhoff PM; De Vivo DC
    Pediatr Res; 1991 Jul; 30(1):1-4. PubMed ID: 1909777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.
    Vlamings R; Visser-Vandewalle V; Koopmans G; Joosten EA; Kozan R; Kaplan S; Steinbusch HW; Temel Y
    Neuroscience; 2007 Sep; 148(3):815-23. PubMed ID: 17706885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postencephalitic parkinsonism and selective involvement of substantia nigra in childhood.
    Rebai I; Ben Rhouma H; Kraoua I; Klaa H; Rouissi A; Ben Youssef-Turki I; Gouider-Khouja N
    Brain Dev; 2015 Jan; 37(1):153-7. PubMed ID: 24745788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.